Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407)

Oncology Group Study ◽

Randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group Study (JCOG1407)

Annals of Oncology ◽

10.1093/annonc/mdx369.151 ◽

2017 ◽

Vol 28 ◽

pp. v263-v264 ◽

Cited By ~ 1

Author(s):

A. Fukutomi ◽

J. Mizusawa ◽

H. Katayama ◽

T. Okusaka ◽

T. Ito ◽

...

Keyword(s):

Pancreatic Cancer ◽

Combination Therapy ◽

Clinical Oncology ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized Phase II Study of Gemcitabine plus S-1 Combination Therapy vs. S-1 in Advanced Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG0805)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq110 ◽

2010 ◽

Vol 40 (12) ◽

pp. 1189-1191 ◽

Cited By ~ 11

Author(s):

A. Takashima ◽

C. Morizane ◽

H. Ishii ◽

K. Nakamura ◽

H. Fukuda ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized Phase II Trial of Gemcitabine Plus S-1 Combination Therapy Versus S-1 in Advanced Biliary Tract Cancer: Results of the Japan Clinical Oncology Group Study (JCOG0805)

Annals of Oncology ◽

10.1093/annonc/mds548 ◽

2012 ◽

Vol 23 ◽

pp. xi15

Author(s):

M. Ikeda ◽

T. Okusaka ◽

J. Mizusawa ◽

A. Takashima ◽

C. Morizane ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505

Annals of Oncology ◽

10.1093/annonc/mdf287 ◽

2002 ◽

Vol 13 (9) ◽

pp. 1347-1355 ◽

Cited By ~ 40

Author(s):

K. Itoh ◽

T. Ohtsu ◽

H. Fukuda ◽

Y. Sasaki ◽

M. Ogura ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized Phase Ii ◽

Non Hodgkin's Lymphoma ◽

Prophylactic Use

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

Gastric Cancer ◽

10.1007/s10120-011-0030-8 ◽

2011 ◽

Vol 14 (3) ◽

pp. 226-233 ◽

Cited By ~ 12

Author(s):

Tetsuya Hamaguchi ◽

◽

Kuniaki Shirao ◽

Atsushi Ohtsu ◽

Ichinosuke Hyodo ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group

Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

International Journal of Hematology ◽

10.1007/s12185-012-1101-2 ◽

2012 ◽

Vol 96 (1) ◽

pp. 74-83 ◽

Cited By ~ 3

Author(s):

Yoshitoyo Kagami ◽

◽

Kuniaki Itoh ◽

Kensei Tobinai ◽

Haruhiko Fukuda ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Intermediate Risk ◽

Newly Diagnosed ◽

Oncology Group ◽

Oncology Group Study ◽

Chop Therapy

A Randomized Phase II/III Trial Comparing Hepatectomy Followed by mFOLFOX6 with Hepatectomy Alone as Treatment for Liver Metastasis from Colorectal Cancer: Japan Clinical Oncology Group Study JCOG0603

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp035 ◽

2009 ◽

Vol 39 (6) ◽

pp. 406-409 ◽

Cited By ~ 37

Author(s):

Y. Kanemitsu ◽

T. Kato ◽

Y. Shimizu ◽

Y. Inaba ◽

Y. Shimada ◽

...

Keyword(s):

Colorectal Cancer ◽

Liver Metastasis ◽

Clinical Oncology ◽

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study

Oncology ◽

10.1159/000074474 ◽

2003 ◽

Vol 65 (3) ◽

pp. 218-223 ◽

Cited By ~ 28

Author(s):

Bryan P. Schneider ◽

Kristen N. Ganjoo ◽

David E. Seitz ◽

Joel Picus ◽

Farid Fata ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Pancreatic Cancer ◽

Oncology Group ◽

Oncology Group Study

A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203

International Journal of Hematology ◽

10.1532/ijh97.05084 ◽

2006 ◽

Vol 83 (1) ◽

pp. 55-62 ◽

Cited By ~ 5

Author(s):

Fumi Mizoroki ◽

Yuko Hirose ◽

Masayuki Sano ◽

Haruhiko Fukuda ◽

Kensei Tobinai ◽

...

Keyword(s):

Elderly Patients ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Aggressive Lymphoma ◽

Oncology Group ◽

Oncology Group Study

A phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: the Japan Clinical Oncology Group trial (JCOG0109)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4071 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4071-4071 ◽

Cited By ~ 1

Author(s):

T. Hamaguchi ◽

A. Ohtsu ◽

I. Hyodo ◽

Y. Arai ◽

H. Takiuchi ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Group Trial